Verve Therapeutics Company
Verve is focused on discovering and developing therapies that safely edit the genomes of adults to confer protection against coronary.
%20.jpg)
Estimated Revenue:
$1M to $10M
Technology:
Small Molecules
Industry:
PharmTech
Funding Status:
Early Stage Venture
Headquarters:
Cambridge, Massachusetts, United States
Founded Date:
2018
Employee Number:
1-10